# The Analgesic Effects of Melatonin

> **NCT01923974** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lars Peter Holst Andersen** · enrollment: 36 (estimated)

## Conditions studied

- Analgesia
- Antihyperalgesia

## Interventions

- **DRUG:** Melatonin 10 mg
- **DRUG:** Melatonin 100 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01923974
- **Lead sponsor:** Lars Peter Holst Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-08
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2014-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923974, "The Analgesic Effects of Melatonin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01923974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*